JournalsHub
.online
Find My Journal
JB

Julie R. Brahmer

Bloomberg (United States) US

ORCID 0000-0002-2443-8395
829
Publications
122,846
Citations
115
H-Index
330
i10-Index
3.52
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer OA
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith +25 more
New England Journal of Medicine 2012
12,546
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer OA
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi +13 more
New England Journal of Medicine 2016
9,936
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer OA
H. Borghaei, L. Paz-Ares, Leora Horn, David R. Spigel, Martin Steins +23 more
New England Journal of Medicine 2015
9,397
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer OA
Julie R. Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried Eberhardt +20 more
New England Journal of Medicine 2015
8,501
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer OA
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian +21 more
New England Journal of Medicine 2012
7,950

Publications

827 total

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer PDF

Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabé, Bogdan Żurawski, Sang‐We Kim et al. - New England Journal of Medicine, 2019
Cited by 2,797 OpenAlex

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater PDF

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi et al. - Journal of Clinical Oncology, 2019
Cited by 1,682 OpenAlex

Genome-wide cell-free DNA fragmentation in patients with cancer PDF

Stephen Cristiano, Alessandro Leal, Jillian Phallen, Jacob Fiksel, Vilmos Adleff et al. - Nature, 2019
Cited by 1,414 OpenAlex

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline PDF

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil et al. - Journal of Clinical Oncology, 2018
Cited by 3,627 OpenAlex

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden PDF

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański, Jong Seok Lee, Gregory A. Otterson et al. - New England Journal of Medicine, 2018
Cited by 3,117 OpenAlex

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer PDF

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, Valsamo Anagnostou, Tricia R. Cottrell et al. - New England Journal of Medicine, 2018
Cited by 2,104 OpenAlex

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer PDF

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi et al. - New England Journal of Medicine, 2016
Cited by 9,936 OpenAlex

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer PDF

H. Borghaei, L. Paz-Ares, Leora Horn, David R. Spigel, Martin Steins et al. - New England Journal of Medicine, 2015
Cited by 9,397 OpenAlex

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer PDF

Julie R. Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried Eberhardt et al. - New England Journal of Medicine, 2015
Cited by 8,501 OpenAlex

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy PDF

Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan et al. - Clinical Cancer Research, 2014
Cited by 2,321 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (410) Lung Cancer Treatments and Mutations (343) Cancer Genomics and Diagnostics (179) Colorectal Cancer Treatments and Studies (132) Lung Cancer Research Studies (122)

Frequent Co-Authors

SU
Suzanne L. Topalian
6 joint publications
DR
Drew M. Pardoll
6 joint publications
JA
Janis M. Taube
5 joint publications
DA
David F. McDermott
3 joint publications
JO
John D. Powderly
3 joint publications
MI
Michael B. Atkins
3 joint publications

Affiliations

University of Southern California
US 2009 - 2009
Uppsala University
SE 2006 - 2005
University of Maryland, Baltimore
US 2007 - 2007
Indiana University Health
US 2017 - 2017
Translational Genomics Research Institute
US 2011 - 2011

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now